oral glp-1 agonist receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and obesity care. Amid the enthusiasm, however, a quieter and clinically important issue is With FDA approval of Wegovy
Description
843-857, Sep
Steiner MD, 19302014: Discoverer of proinsulin', Proceedings of the National Academy of Sciences , 12/4, 940-1

doi:10.2337/dc11-s231 Jensterle M, Rizzo M, Haluzk M, Jane A

Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem

A.QuastD
ArticlePubMed 68
